Paraytec
Paraytec - UV Area Imaging.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
N/A | Grant | ||
| Total Funding | 000k | ||
| GBP | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 1 % | (49 %) | 1 % | (10 %) | 53 % | 3 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (27 %) | (78 %) | (26 %) | (35 %) | 5 % | 5 % | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (34 %) | (64 %) | (15 %) | (24 %) | 7 % | 7 % | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | 72 % | 80 % | 87 % | - | - |
Source: Company filings or news article
Related Content
Paraytec is a UK-based scientific instrument company specializing in the development of high-performance fluid flow and particle detectors for the analytical and life sciences instrumentation market. The company holds a suite of five core technology patents and several additional patent applications, focusing on fast and sensitive optical particle analysis. Paraytec's innovations span biochemistry, equipment hardware, and software, creating a broad range of intellectual property.
The company serves clients in the pharmaceutical and biopharmaceutical sectors, providing advanced analytical solutions that enhance research and development processes. Paraytec's business model revolves around the sale and licensing of its proprietary technology, generating revenue through direct sales, partnerships, and collaborations with industry leaders.
Chief Scientific Officer David, an award-winning Analytical Scientist, leads the development team, focusing on miniaturized optical detectors and multidisciplinary projects. Executive Director Viv oversees business operations and represents the parent company, Braveheart Investment Group, leveraging his extensive experience in new product development and advanced technology companies.
Paraytec's flagship product, the D200 Large Area Imager, utilizes Optical Taper Technology to increase detection areas, making it ideal for Lab on a Chip and large flow cell applications. The company's expertise in optical particle analysis also extends to the field of gene therapy, particularly with adeno-associated viruses (AAV), which are widely used as viral vectors.
Keywords: fluid flow detectors, particle detectors, optical analysis, biochemistry, pharmaceutical, biopharmaceutical, intellectual property, gene therapy, Lab on a Chip, Optical Taper Technology.